Free Trial

Universe Pharmaceuticals (UPC) Competitors

Universe Pharmaceuticals logo
$3.50 +0.07 (+2.04%)
Closing price 08/22/2025 03:57 PM Eastern
Extended Trading
$3.58 +0.08 (+2.40%)
As of 08/22/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UPC vs. EVOK, KPRX, CELZ, NLSP, MBIO, CYCN, APM, AEON, ALZN, and GNPX

Should you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Evoke Pharma (EVOK), Kiora Pharmaceuticals (KPRX), Creative Medical Technology (CELZ), NLS Pharmaceutics (NLSP), Mustang Bio (MBIO), Cyclerion Therapeutics (CYCN), Aptorum Group (APM), AEON Biopharma (AEON), Alzamend Neuro (ALZN), and GENPREX (GNPX). These companies are all part of the "pharmaceutical products" industry.

Universe Pharmaceuticals vs. Its Competitors

Universe Pharmaceuticals (NYSE:UPC) and Evoke Pharma (NASDAQ:EVOK) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Universe Pharmaceuticals has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, Evoke Pharma has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500.

In the previous week, Evoke Pharma had 2 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 2 mentions for Evoke Pharma and 0 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.00 beat Evoke Pharma's score of -0.27 indicating that Universe Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Universe Pharmaceuticals Neutral
Evoke Pharma Neutral

0.2% of Universe Pharmaceuticals shares are owned by institutional investors. 57.4% of Universe Pharmaceuticals shares are owned by insiders. Comparatively, 2.3% of Evoke Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Evoke Pharma has lower revenue, but higher earnings than Universe Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Universe Pharmaceuticals$19.29M0.10-$6.16MN/AN/A
Evoke Pharma$10.25M0.84-$5.35M-$2.56-2.16

Universe Pharmaceuticals has a net margin of 0.00% compared to Evoke Pharma's net margin of -42.07%. Universe Pharmaceuticals' return on equity of 0.00% beat Evoke Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Universe PharmaceuticalsN/A N/A N/A
Evoke Pharma -42.07%-99.48%-33.58%

Summary

Universe Pharmaceuticals beats Evoke Pharma on 8 of the 11 factors compared between the two stocks.

Get Universe Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPC vs. The Competition

MetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE Exchange
Market Cap$1.96M$837.08M$5.83B$21.32B
Dividend YieldN/A4.84%4.40%3.51%
P/E RatioN/A1.1622.8126.68
Price / Sales0.1026.35473.1755.22
Price / CashN/A19.5638.0224.09
Price / Book0.026.649.535.47
Net Income-$6.16M-$4.94M$3.26B$992.74M
7 Day Performance-1.82%1.85%2.14%2.68%
1 Month Performance-8.62%2.72%2.81%1.53%
1 Year Performance-99.82%10.97%30.70%10.77%

Universe Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPC
Universe Pharmaceuticals
N/A$3.50
+2.0%
N/A-99.8%$1.96M$19.29M0.00220
EVOK
Evoke Pharma
0.577 of 5 stars
$5.12
-6.4%
N/A+24.8%$7.64M$10.25M-1.794Gap Down
KPRX
Kiora Pharmaceuticals
2.7639 of 5 stars
$2.51
+2.2%
$10.00
+299.2%
-26.2%$7.62M$16.02M-0.8610Gap Up
CELZ
Creative Medical Technology
1.7209 of 5 stars
$2.94
+0.5%
N/A-7.5%$7.60M$10K-0.925News Coverage
Short Interest ↓
NLSP
NLS Pharmaceutics
N/A$2.08
+0.1%
N/A+1,379.2%$7.49MN/A0.006Short Interest ↓
Gap Up
MBIO
Mustang Bio
0.4537 of 5 stars
$1.71
-3.1%
N/A-91.3%$7.47MN/A-0.02100Positive News
Gap Down
CYCN
Cyclerion Therapeutics
1.5167 of 5 stars
$2.22
+2.5%
N/A-4.4%$7.43M$2M-3.0130Positive News
Short Interest ↓
APM
Aptorum Group
0.7324 of 5 stars
$1.38
-2.8%
N/A-12.6%$7.38M$430K0.0030News Coverage
Gap Down
AEON
AEON Biopharma
2.8993 of 5 stars
$0.63
-3.7%
$360.00
+56,862.0%
-98.9%$7.15MN/A3.515Gap Down
ALZN
Alzamend Neuro
2.5677 of 5 stars
$2.44
+1.7%
$180.00
+7,277.0%
-91.8%$7.08MN/A0.004Analyst Forecast
GNPX
GENPREX
1.6084 of 5 stars
$0.21
-0.8%
N/A-76.0%$7.03MN/A0.0020Gap Up

Related Companies and Tools


This page (NYSE:UPC) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners